The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Effect of Iron Chelation Therapy on Recovery from Deep Coma in Children with Cerebral Malaria
Open accessAbstract
BACKGROUND: Cerebral malaria is a severe complication of Plasmodium falciparum infection in children, with a mortality rate of 15 to 50 percent despite antimalarial therapy. METHODS: To determine whether combining iron chelation with quinine therapy speeds the recovery of consciousness, we conducted a randomized, double-blind, placebo-controlled trial of the iron chelator deferoxamine in 83 Zambian children with cerebral malaria. To be enrolled, patients had to be less than six years old, have P. falciparum parasitemia, have normal cerebrospinal fluid without evidence of bacterial infection, and be in a coma from which they could not be aroused. Deferoxamine (100 mg per kilogram of body weight per day, infused intravenously for 72 hours) or placebo was added to standard therapy with quinine and sulfadoxine-pyrimethamine. The time to the recovery of full consciousness, time to parasite clearance, and mortality were examined with Cox proportional-hazards regression analysis. RESULTS: The rate of recovery of full consciousness among the 42 patients given deferoxamine was 1.3 times that among the 41 given placebo (95 percent confidence interval, 0.7 to 2.3); the median time to recovery was 20.2 hours in the deferoxamine group and 43.1 hours in the placebo group (P = 0.38). Among 50 patients with deep coma, the rate of recovery of full consciousness was increased 2.2-fold with deferoxamine (95 percent confidence interval, 1.1 to 4.7), decreasing the median recovery time from 68.2 to 24.1 hours (P = 0.03). Among 69 patients for whom data on parasite clearance were available, the rate of clearance with deferoxamine was 2.0 times that with placebo (95 percent confidence interval, 1.2 to 3.6). Among all 83 patients, mortality was 17 percent in the deferoxamine group and 22 percent in the placebo group (P = 0.52). CONCLUSIONS: Iron chelation therapy may hasten the clearance of parasitemia and enhance recovery from deep coma in cerebral malaria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Along this line children suffering from cerebral malaria benefited from the addition of the iron chelator desferrioxamine to a standard anti-malaria treatment, as reflected by faster recurrence from coma and clearance of plasmodia, although this did not translate into a survival benefit (Gordeuk et al., 1992; Mabeza et al., 1999), although anti-plasmodial innate immune responses were positively”
From Iron at the interface of immunity and infection (2014) · cites this paper as Gordeuk et al., 1992
Experimental — accuracy not yet measuredIn the citing paper
“the malarial parasite Plasmodium falciparum requires considerable iron for growth, and there is evidence that lowering the amount of available iron provides a promising route to antimalarials (e.g. [1478-1494]”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1481]
In the citing paper
“Systemic Fe chelation by desferrioxamine can improve the clinical course of malaria, without, however, providing an overt survival benefit [236].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [236]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
MacPherson, G. G., Warrell, M. J., White, N. J., Looareesuwan, S., & Warrell, D. A. (1985) · PubMed Central · Cited by 825
Molyneux, M. E., Taylor, T. E., Wirima, J. J., & Borgstein, A. (1989) · QJM · doi:10.1093/oxfordjournals.qjmed.a068338 · Cited by 691
Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins.
Henson, P. M., & Johnston, R. B. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112869 · Cited by 688
Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa
Greenwood, B. M., Bradley, A. K., Greenwood, A. M., Byass, P., Jammeh, K., Marsh, K., Tulloch, S., Oldfield, F. S. J., & Hayes, R. (1987) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(87)90170-2 · Cited by 622
Hemoglobin. A biologic fenton reagent.
Sadrzadeh, S. M. H., Graf, E., Panter, S. S., Hallaway, P. E., & Eaton, J. W. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42604-4 · Cited by 589
Neurological sequelae of cerebral malaria in children
Brewster, D., Kwiatkowski, D. P., & White, N. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)92498-7 · Cited by 407
Aikawa, M. (1988) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1988.39.3 · Cited by 343
Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury.
Ward, P. A., Till, G. O., Kunkel, R., & Beauchamp, C. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111050 · Cited by 336
Research works printed but not linked: 3
- Molyneux, 1989, Q J Med, 71, 441
- 1978, WHO Chron, 32, 9
- MacPherson, 1985, Am J Pathol, 119, 385
Cited by
Sorted by citations
Items 101–200 of 218
Nutrition, immunity and infection
(2010) · CABI eBooks · doi:10.1079/9780851995311.0000 · Cited by 28
TIME COURSE OF IRON METABOLISM IN CRITICALLY ILL PATIENTS
Piagnerelli, M., COTTON, F. J., Herpain, A., Rapotec, A., Chatti, R., Gulbis, B., & Vincent, J.-L. (2013) · Acta Clinica Belgica · doi:10.2143/acb.68.1.2062715 · Cited by 27
An extended-release formulation of desferrioxamine for subcutaneous administration
Toliyat, T., Jorjani, M., & Khorasanirad, Z. (2009) · Drug Delivery · doi:10.1080/10717540903141768 · Cited by 27
Transferrin saturation and recovery from coma in cerebral malaria
Gordeuk, V., Thuma, P., McLaren, C., Biemba, G., Zulu, S., Poltera, A. A., Askin, J., & Brittenham, G. (1995) · Blood · doi:10.1182/blood.v85.11.3297.bloodjournal85113297 · Cited by 27
Self-citationThe Treatment of Malaria with Iron Chelators
Hider, R. C., & Liu, Z. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06162.x · Cited by 26
Duan, H., Zhao, S., Xiang, J., Ju, C., Chen, X., Gramaglia, I., & Yan, X. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00582-8 · Cited by 26
Iron and infection in the tropics: paediatric clinical correlates
Oppenheimer, S. (1998) · Annals of Tropical Paediatrics · doi:10.1080/02724936.1998.11747985 · Cited by 26
Persistent cognitive impairment after cerebral malaria: models, mechanisms and adjunctive therapies
Zimmerman, G. A., & Castro-Faria-Neto, H. C. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.117 · Cited by 25
Nguyen, S. T., Du, D., Wychrij, D., Cain, M. D., Wu, Q., Klein, R. S., Russo, I., & Goldberg, D. E. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2306318120 · Cited by 24
Predictors of severity of illness on presentation in children with cerebral malaria
Mabeza, G. F., Moyo, V. M., Thuma, P. E., Biemba, G., Parry, D., Khumalo, H., Nyarugwe, P., Zulu, S., & Gordeuk, V. R. (1995) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1995.11812947 · Cited by 24
Self-citationDeferoxamine: Stimulation of hematin polymerization and antagonism of its inhibition by chloroquine
Vippagunta, S. R., Dorn, A., Bubendorf, A., Ridley, R. G., & Vennerstrom, J. L. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00161-6 · Cited by 23
The association of pallor with haemoglobin concentration and mortality in severe malaria
Mabeza, G. F., Biemba, G., Brennan, A. G., Moyo, V. M., Thuma, P. E., & Gordeuk, V. R. (1998) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034989859122 · Cited by 23
Self-citationLoading dose of quinine in African children with cerebral malaria
van der Torn, M., Thuma, P. E., Mabeza, G. F., Biemba, G., Moyo, V. M., McLaren, C. E., Brittenham, G. M., & Gordeuk, V. R. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)91032-x · Cited by 23
Self-citationBark, Weeds, and Iron Chelators — Drugs for Malaria
Wyler, D. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211193272110 · Cited by 23
Implications of Resource-Ratio Theory for Microbial Ecology
Smith, V. H. (1993) · Advances in microbial ecology · doi:10.1007/978-1-4615-2858-6_1 · Cited by 22
Arantes, J. M., Francisco, A. F., Vieira, P. M. D. A., Silva, M., Araújo, M. S. S., Teixeira‐Carvalho, A., Pedrosa, M. L., Carneiro, C. M., Tafuri, W. L., Martins‐Filho, O. A., et al. (2011) · Experimental Parasitology · doi:10.1016/j.exppara.2011.05.011 · Cited by 21
Management of Severe Malaria in the Intensive Care Unit
Cheng, M. P., & Yansouni, C. P. (2013) · Critical Care Clinics · doi:10.1016/j.ccc.2013.06.008 · Cited by 21
Loyevsky, M., Sacci, J. B., Boehme, P., Weglicki, W. B., John, C. S., & Gordeuk, V. R. (1999) · Experimental Parasitology · doi:10.1006/expr.1998.4371 · Cited by 21
Self-citationLooareesuwan, S., Wilairatana, P., Vannaphan, S., Gordeuk, V. R., Taylor, T. E., Meshnick, S., & Brittenham, G. M. (1996) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1996.11813081 · Cited by 21
Self-citationPlasmodium vinckei:Optimization of Desferrioxamine B Delivery in the Treatment of Murine Malaria
Postma, N. S., Hermsen, C. C., Zuidema, J., & Eling, W. M. C. (1998) · Experimental Parasitology · doi:10.1006/expr.1998.4282 · Cited by 20
Potentiation by febrifugine of host defense in mice against plasmodium berghei NK65
Murata, K., Takano, F., Fushiya, S., & Oshima, Y. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00244-0 · Cited by 20
CD19(+) B Cells Confer Protection against Experimental Cerebral Malaria in Semi-Immune Rodent Model
Lam, B., Huy, N. T., Kikuchi, M., Yanagi, T., Senba, M., Shuaibu, M. N., Honma, K., Yui, K., & Hirayama, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064836 · Cited by 19
Stanley, J. (1997) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(05)70288-1 · Cited by 19
Drug-Resistant Malaria in Children and in Travelers
Longworth, D. L. (1995) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)38983-0 · Cited by 19
Can Iron Chelators Influence the Progression of Atherosclerosis?
Marx, J. J. M., Kartikasari, A. E. R., & Georgiou, N. (2008) · Hemoglobin · doi:10.1080/03630260701726871 · Cited by 18
10 Oral iron-chelating therapy: the L1 experience
Al‐Refaie, F. N., & Hoffbrand, A. V. (1994) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80132-5 · Cited by 18
Pradines, B., Ramiandrasoa, F., Rolain, J., Rogier, C., Mosnier, J., Daries, W., Fusaı̈, T., Kunesch, G., Bras, J. L., & Parzy, D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.225-228.2002 · Cited by 16
Orchestrating a heist: uptake and storage of metals by apicomplexan parasites
Sloan, M. A., Aghabi, D., & Harding, C. R. (2021) · Microbiology · doi:10.1099/mic.0.001114 · Cited by 16
Srivastava, N. K., Mukherjee, S., & Mishra, V. N. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.10.006 · Cited by 17
Presence of pro-oxidants in plasma of patients suffering from falciparum malaria
Nanda, N. K., & Das, B. S. (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90233-5 · Cited by 15
Lademann, M., GABELIN, P., Lafrenz, M., WERNITZ, C., EHMKE, H., SCHMITZ, H. E., & Reisinger, E. C. (2005) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2005.72.478 · Cited by 15
Iron Chelation Therapy for Malaria
Gordeuk, V. R., Thuma, P. E., & Brittenham, G. M. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2554-7_39 · Cited by 15
Self-citationWeiß, G., Kastner, S., Brock, J. H., Thaler, J., & Grünewald, K. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00894-5 · Cited by 15
Antimalarial Effect of Iron Chelators
Gordeuk, V. R., & Loyevsky, M. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0593-8_13 · Cited by 13
Self-citationSonnet, P., & Mullié, C. (2011) · Experimental Parasitology · doi:10.1016/j.exppara.2011.01.018 · Cited by 13
Aminothiol multidentate chelators as antimalarials
Loyevsky, M., John, C. S., Zaloujnyi, I., & Gordeuk, V. R. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00185-8 · Cited by 13
Self-citationIron and the Reticuloendothelial System
Weiß, G. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_11 · Cited by 13
Assessment of antimalarial effect of ICL670A on in vitro cultures of Plasmodium falciparum
Goudeau, C., Loyevsky, M., Kassim, O. O., Gordeuk, V. R., & Nick, H. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03159.x · Cited by 12
Self-citationWhy is Babesia not killed by artemisinin like Plasmodium?
Si, W., Fang, C., Liu, C., Yin, M., Xu, W., Li, Y., Yan, X., Shen, Y., Cao, J., & Sun, J. (2023) · Parasites & Vectors · doi:10.1186/s13071-023-05783-4 · Cited by 11
Improving Cognitive Outcome in Cerebral Malaria: Insights from Clinical and Experimental Research
de Miranda, A. S., Brant, F., Machado, F. S., Rachid, M. A., & Teixeira, A. L. (2011) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524911106040285 · Cited by 11
Postma, N. S., Boerman, O. C., Oyen, W. J. G., Zuidema, J., & Storm, G. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00139-4 · Cited by 11
Clinical malaria in the tropics
White, N. J., & Pukrittayakamee, S. (1993) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb137788.x · Cited by 11
Pattanapanyasat, K., Kotipun, K., Yongvanitchit, K., Hider, R. C., Kyle, D. E., Heppner, D., & Ds, W. (2001) · PubMed · Cited by 10
Molecular targets in cerebral malaria for developing novel therapeutic strategies
Ravisankar, V., Nakka, V. P., Simhadri, P. K., Baruah, U. K., & Babu, P. P. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.01.020 · Cited by 10
Malaria: Pathogenicity and Disease
English, M., & Newton, C. R. J. C. (2002) · KARGER eBooks · doi:10.1159/000058842 · Cited by 10
Recognition and management of imported malaria in children
Shingadia, D. V., & Shulman, S. T. (2000) · Seminars in Pediatric Infectious Diseases · doi:10.1053/pi.2000.6227 · Cited by 10
Rotheneder, A., Fritsche, G., Heinisch, L., Möllmann, U., Heggemann, S., Larcher, C., & Weiß, G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.2010-2013.2002 · Cited by 10
Synthesis and antimalarial activity of amide and ester conjugates of siderophores and ozonides
Tiwari, R., Checkley, L. A., Ferdig, M. T., Vennerstrom, J. L., & Miller, M. J. (2022) · BioMetals · doi:10.1007/s10534-022-00375-8 · Cited by 9
(2005) · Wiley eBooks · doi:10.1002/0471743984.vse4298 · Cited by 9
Shankar, A. H. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-464-3_9 · Cited by 8
Functional Consequences of Nutritional Anemia in Adults
Beard, J. (2000) · Modern nutrition · doi:10.1201/9781420036787.ch7 · Cited by 8
Are Studies on Severe Malaria Still Possible?
Shanks, G. D. (2009) · Clinical Infectious Diseases · doi:10.1086/605432 · Cited by 8
Ray, S., Fuller, C. E., Boubour, A., Tshimangani, T., Kafoteka, E., Liomba, A. M., Malenga, A., Tebulo, A., Pensulo, P., Gushu, M. B., et al. (2025) · The Lancet Global Health · doi:10.1016/s2214-109x(25)00055-5 · Cited by 7
Hammadi, A., Ramiandrasoa, F., Sinou, V., Rogier, C., Fusaı̈, T., Bras, J. L., Parzy, D., Kunesch, G., & Pradines, B. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00042-x · Cited by 7
Potential molecular targets of metabolic pathways
Boyle, S. M., Szaniszlo, P. J., Nozawa, Y., Jacobson, E. S., & Cole, G. T. (1994) · Medical Mycology · doi:10.1080/02681219480000741 · Cited by 7
Therapeutic Use of Chelating Agents in Iron Overload
Templeton, D. M. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-79162-8_14 · Cited by 6
Plasmodies - Malaria : Formes cliniques, diagnostic
Malvy, D. J.-M., Djossou, F., Thiébaut, R., & Bras, M. L. (2000) · EMC-Maladies infectieuses/Encyclopédie médico-chirurgicale. Maladies infectieuses · doi:10.1016/s1166-8598(00)00020-x · Cited by 6
Anstey, N. M., Weinberg, J. B., & Granger, D. L. (2002) · Springer eBooks · doi:10.1007/0-306-46816-6_15 · Cited by 6
Lytton, S. D., Loyevsky, M., Libman, J., Mester, B., Shanzer, A., & Cabantchik, Z. I. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2554-7_40 · Cited by 6
Effects of iron chelating agent on Schistosoma mansoni infected murine model
Abdelgelil, N. H., Abdellatif, M. Z. M., Abdel-Hafeez, E. H., Belal, U. S., Mohamed, R. M., Abdel‐Razik, A. H., Hassanin, K. M. A., & Abdel‐Wahab, A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.036 · Cited by 5
Iron Metabolism in Cancer and Infection
Nekhai, S. A., & Gordeuk, V. R. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_24 · Cited by 5
Self-citationBanerjee, A. (1999) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(00)87128-0 · Cited by 5
(2005) · Wiley eBooks · doi:10.1002/0471740039.vec1405 · Cited by 5
Parenteral iron—Does it increase infection risk?
Deb, J., Mohan, A. K., Sil, S., Datta, S. S., Nagandran, Y., Maji, M., Majumder, M. K. H., & Mandal, S. (2026) · Vox Sanguinis · doi:10.1111/vox.70241 · Cited by 4
Roberts, L. J. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.10.042 · Cited by 4
Recent developments in the management of malaria
Woodrow, C. J., Riberio, I., & Krishna, S. (1999) · The Indian Journal of Pediatrics · doi:10.1007/bf02752365 · Cited by 4
Weiß, G. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-652-2_11 · Cited by 4
Taylor, T. E., & Agbenyega, T. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-4390-4.00096-5 · Cited by 4
Paludisme grave : Apport de l'exsanguino-transfusion
Santré, C., Leroy, O., Fourrier, F., Georges, H., Guery, B. P., Beuscart, C., Forget, A. P., & Beaucaire, G. (1994) · Réanimation Urgences · doi:10.1016/s1164-6756(05)80706-6 · Cited by 4
Drug Information Analysis Service
Schroeder, D. J., Hart, L. L., & Lynch, S. S. (1994) · Annals of Pharmacotherapy · doi:10.1177/106002809402800509 · Cited by 4
Double-kill mechanism of artemisinin against PlasmodiumPreprint
Sun, J., Guo, F., Liu, C., Chen, B., Xu, W., Li, J., Du, X., Liu, Y., & Wang, Y. (2022) · Research Square · doi:10.21203/rs.3.rs-1645582/v1 · Cited by 4
Folate deficiency to protect against malaria.
Taylor, T. E., & Molyneux, M. E. (1993) · PubMed · Cited by 3
Advances in Pediatric Pharmacology and Toxicology
Berlin, C. M. (1995) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00126-9 · Cited by 2
Chêne, A. (2009) · Figshare · Cited by 2
Adjunctive Therapies for Malaria
Higgins, S. J., Elphinstone, R. E., & Kain, K. C. (2014) · Springer eBooks · doi:10.1007/978-1-4614-8326-7_123 · Cited by 2
Folate Deficiency to Protect against Malaria
Herbert, V. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304153281514 · Cited by 2
New Directions in Iron Chelating Therapy
Hershko, C., & Link, G. (1996) · Springer eBooks · doi:10.1007/978-1-4613-0391-6_79 · Cited by 2
Host iron deficiency protects against Plasmodium infection and drives parasite molecular reprofiling
Clucas, D. B., Bennett, C., Harding, R., Pettikiriarachchi, A., Baldi, A., Randall, L. M., Steel, R. W. J., Mellin, R., Hobbs, M., Caiazzo, S., et al. (2026) · Science Advances · doi:10.1126/sciadv.aeb0828 · Cited by 1
Overview Anti-infectives: The treatment of malaria with iron chelators
Hider, R. C. (1994) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.4.8.931 · Cited by 1
Novel Therapeutic Agents in Pediatric Sepsis - Zinc
Nowak, J. E. (2011) · The Open Inflammation Journal · doi:10.2174/1875041901104010110 · Cited by 1
Linkage of Pteridine Metabolism to Iron Homeostasis
Weiß, G. (2004) · Pteridines · doi:10.1515/pteridines.2004.15.3.120 · Cited by 1
Transition Metals in Catalysis and Electron Transport
Metzler, D. E., Metzler, C. M., & Sauke, D. J. (2001) · Elsevier eBooks · doi:10.1016/b978-012492543-4/50019-2 · Cited by 1
Wada, A., & Asahi, H. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00846 · Cited by 1
Etiology of Metabolic Changes in Severe Plasmodium falciparum Malaria
Eisenhut, M. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv084 · Cited by 1
Krogstad, D. J., Suzuki, M., Long, C. A., Aoki, Y., Ishii, A., & James, S. L. (1994) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1994.51.384 · Cited by 1
Bronchodilators: wrong for the lung in the long run?
van Schayck, O. C. P. (1993) · PubMed Central · Cited by 1
Gachot, B., Doyon, F., & Hill, C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612193352512 · Cited by 1
Blumberg, L. (2005) · Perspectives on critical care infectious diseases · doi:10.1007/0-387-23380-6_1 · Cited by 1
Desferrioxamine and cerebral malaria
(1992) · The Lancet · doi:10.1016/0140-6736(92)92566-x · Cited by 1
Hommel, M., & Gilles, H. M. (2010) · doi:10.1002/9780470688618.taw0189 · Cited by 1
Loyevsky, M., & Gordeuk, V. R. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-111-4_17 · Cited by 1
Self-citationBras, M. L. (1994) · Réanimation Urgences · doi:10.1016/s1164-6756(05)80705-4
Ei, H., & Babikir, H. (2010)
Aus dem Institut für Tropenmedizin der Universität Tübingen Direktor: Professor Dr. J. Knobloch
Humanparasitologie, S., & Kremsner, P. G. (2004)
Casals‐Pascual, C., Idro, R., Gicheru, N., Gwer, S., Kitsao, B. S., Gitau, E., Mwakesi, R., Roberts, D. J., & Newton, C. R. J. C. (2008)
Clinical Studies of Iron-Chelating Treatment in Malaria
Gordeuk, V. R., Biemba, G., & Thuma, P. E. (1996) · Springer eBooks · doi:10.1007/978-1-4613-0391-6_83
Self-citationCerebral Malaria: Players in the Pathogenic Mechanism and Treatment Strategies
Dwivedi‐Agnihotri, H., & Tripathi, R. (2018) · Springer eBooks · doi:10.1007/978-981-13-1577-0_3
Chopra, J. S., & Sawhney, I. M. S. (2003) · Elsevier eBooks · doi:10.1016/b978-012125831-3/50247-1
Metadata
- Authors
- Gordeuk, V., Thuma, P., Brittenham, G., McLaren, C., Parry, D., Backenstose, A., Biemba, G., Msiska, R., Holmes, L., McKinley, E., Vargas, L., Gilkeson, R., & Poltera, A. A.
- Affiliations
- MetroHealth Medical Center (US)
- Pennsylvania State University (US)
- Minnesota State University Moorhead (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1992-11-19
- Volume
- 327
- Issue
- 21
- Pages
- 1473-1477
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1983646126
- Cited by
- 210
- References
- 23
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 4 · 2018: 3 · 2016: 1 · 2015: 4 · 2014: 6 · 2013: 4 · 2012: 6
- FWCI
- 19.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl042814-05)
- U.S. Food and Drug Administration (FD-R-000657-01)
- National Heart, Lung, and Blood Institute (R01 HL42814-02)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- cerebral malaria, iron chelation, deferoxamine, deep coma, consciousness recovery, Plasmodium falciparum, quinine, sulfadoxine-pyrimethamine, parasite clearance, mortality, children
- MeSH terms
- Child, Preschool, Coma, Consciousness, Deferoxamine, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Pyrimethamine, Quinine, Sulfadoxine, Time Factors, Proportional Hazards Models, Malaria, Cerebral
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
